| WKN: | A2JLT3 |
| ISIN: | SE0011205202 |
| Land: | Schweden |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Gesundheit |
Weshalb die Vitrolife-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 09. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 21,56 | 52,85 | 145,13% |
| 2 | 2013 | 0,91 | 2,05 | 125,27% |
| 3 | 2003 | 0,20 | 0,37 | 85,00% |
| 4 | 2015 | 3,42 | 6,02 | 76,02% |
| 5 | 2009 | 0,29 | 0,51 | 75,86% |
| 6 | 2014 | 2,05 | 3,42 | 66,83% |
| 7 | 2017 | 8,18 | 12,66 | 54,77% |
| 8 | 2019 | 14,09 | 19,22 | 36,41% |
| 9 | 2016 | 6,02 | 8,18 | 35,88% |
| 10 | 2006 | 0,44 | 0,57 | 29,55% |
| 11 | 2005 | 0,34 | 0,44 | 29,41% |
| 12 | 2011 | 0,63 | 0,78 | 23,81% |
| 13 | 2010 | 0,51 | 0,63 | 23,53% |
| 14 | 2012 | 0,78 | 0,91 | 16,67% |
| 15 | 2020 | 19,22 | 21,56 | 12,17% |
| 16 | 2018 | 12,66 | 14,09 | 11,30% |
| 17 | 2024 | 17,59 | 18,89 | 7,39% |
| 18 | 2023 | 17,02 | 17,59 | 3,35% |
| 19 | 2004 | 0,37 | 0,34 | -8,11% |
| 20 | 2007 | 0,57 | 0,46 | -19,30% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 52,85 | 17,02 | -67,80% |
| 2 | 2002 | 0,50 | 0,20 | -60,00% |
| 3 | 2008 | 0,46 | 0,29 | -36,96% |
| 4 | 2025 | 18,89 | 12,48 | -33,93% |
| 5 | 2026 | 12,48 | 8,57 | -31,33% |
| 6 | 2007 | 0,57 | 0,46 | -19,30% |
| 7 | 2004 | 0,37 | 0,34 | -8,11% |
| 8 | 2023 | 17,02 | 17,59 | 3,35% |
| 9 | 2024 | 17,59 | 18,89 | 7,39% |
| 10 | 2018 | 12,66 | 14,09 | 11,30% |
| 11 | 2020 | 19,22 | 21,56 | 12,17% |
| 12 | 2012 | 0,78 | 0,91 | 16,67% |
| 13 | 2010 | 0,51 | 0,63 | 23,53% |
| 14 | 2011 | 0,63 | 0,78 | 23,81% |
| 15 | 2005 | 0,34 | 0,44 | 29,41% |
| 16 | 2006 | 0,44 | 0,57 | 29,55% |
| 17 | 2016 | 6,02 | 8,18 | 35,88% |
| 18 | 2019 | 14,09 | 19,22 | 36,41% |
| 19 | 2017 | 8,18 | 12,66 | 54,77% |
| 20 | 2014 | 2,05 | 3,42 | 66,83% |